A61K 39/295
Polyvalent viral antigens
Official title: Polyvalent viral antigens (vaccinia virus or variola virus A61K39/285); Mixtures of viral and bacterial antigens
A61K39/295 (Polyvalent viral antigens) appears on 169 US grants and 305 published applications in this corpus.
Search patents in A61K- Granted patents
- 169
- Published applications
- 305
- Assignees
- 161
- Inventors
- 597
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 2 | 9 |
| 2010 | 3 | 5 |
| 2011 | 2 | 6 |
| 2012 | 2 | 5 |
| 2013 | 1 | 16 |
| 2014 | 10 | 15 |
| 2015 | 10 | 13 |
| 2016 | 10 | 11 |
| 2017 | 11 | 14 |
| 2018 | 9 | 20 |
| 2019 | 17 | 24 |
| 2020 | 13 | 20 |
| 2021 | 18 | 33 |
| 2022 | 15 | 23 |
| 2023 | 13 | 25 |
| 2024 | 10 | 29 |
| 2025 | 14 | 13 |
| 2026 | 7 | 15 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Dengue vaccine unit dose and administration thereof29 Sep 2026US 12,746,283 B2Takeda Vaccines, Inc.
- Self-assembling insect ferritin nanoparticles21 Apr 2026US 12,606,596 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Combination of vaccines to prophylactically treat a pig7 Apr 2026US 12,594,328 B2Intervet Inc.
- Combined norovirus and rotavirus vaccine composition and methods of preparation31 Mar 2026US 12,589,144 B2Bharat Biotech International Limited
- Multivalent HVT vector vaccine31 Mar 2026US 12,589,147 B2Intervet Inc.
- Dengue virus serotype-specific modulation of t cell responses8 Oct 2026US 2026/0306621 A1The United States Government as represented by the Department of Veterans Affairs
- Hiv vaccine24 Sep 2026US 2026/0284176 A1
- Broad-spectrum multi-antigen pan-coronavirus vaccine3 Sep 2026US 2026/0256905 A1The Regents of the University of California
- Fusion polypeptides, immunogenic compositions, methods and uses thereof20 Aug 2026US 2026/0240986 A1University of Saskatchewan
- Pharmaceutical compositions for delivery of herpes simplex virus glycoprotein c, glycoprotein d, and glycoprotein e antigens and related methods13 Aug 2026US 2026/0232791 A1BioNTech SE
Most cited
By later US patents
- Respiratory virus nucleic acid vaccines53US 11,103,578 B2ModernaTX, Inc. · 2021
- Transcutaneous delivery of therapeutic agents49US 8,728,491 B2Alba Therapeutics Corporation · 2014
- Multi plasmid system for the production of influenza virus30US 8,354,114 B2MedImmune, LLC · 2013
- Avirulent, immunogenic flavivirus chimeras29US 7,094,411 B2The United States of America as represented by the Department of Health and Human Services · 2006
- Avirulent, immunogenic flavivirus chimeras21US 8,673,316 B2Mahidol University · 2014